UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diroximel fumarate pregnancy outcomes in EVOLVE-MS-1 and prospective MS pregnancy exposure registry study design

Journal of neurology, neurosurgery and psychiatry, 2023-11, Vol.94 (Suppl 1), p.A67-A67

2023

Volltextzugriff (PDF)

Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis

CNS drugs, 2023-05, Vol.37 (5), p.441-452

2023

Volltextzugriff (PDF)

Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”

Neurology and therapy, 2023-12, Vol.12 (6), p.2199-2203

2023

Volltextzugriff (PDF)

Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis

Neurology and therapy, 2023-02, Vol.12 (1), p.145-159

2023

Volltextzugriff (PDF)

Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM

Neurology and therapy, 2023-10, Vol.12 (5), p.1669-1682

2023

Volltextzugriff (PDF)

Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons

Journal of comparative effectiveness research, 2024-10, Vol.13 (10), p.e230161

2024

Volltextzugriff (PDF)

Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration

PloS one, 2015-07, Vol.10 (7), p.e0128386-e0128386

2015

Volltextzugriff (PDF)

Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase

Multiple sclerosis journal - experimental, translational and clinical, 2024-04, Vol.10 (2), p.20552173241247182-20552173241247182

2024

Volltextzugriff (PDF)

Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 after Re-baselining in the Phase 3 EVOLVE-MS-1 Study (P8-3.001)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Long-Term Safety and Effectiveness of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice, an updated analysis of the ESTEEM Study (P7-3.009)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Diroximel Fumarate Pregnancy Outcomes in EVOLVE-MS-1 and Study Design of Diroximel Fumarate Prospective MS Pregnancy Exposure Registry (P9-3.003)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Long-Term Safety and Effectiveness of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice (P7-4.009)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Über die anwendung der ultrahochfeld-magnetresonanztomographie zur detektion verschiedener läsionsmuster bei patienten mit multipler sklerose

Bozin, Ivan

2016

Volltextzugriff (PDF)

Diroximel Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 Study

Advances in therapy, 2024-08, Vol.41 (8), p.3396-3406

2024

Volltextzugriff (PDF)

Identical lesion morphology in primary progressive and relapsing–remitting MS –an ultrahigh field MRI study

Multiple sclerosis, 2014-12, Vol.20 (14), p.1866-1871

2014

Volltextzugriff (PDF)

Vaccine response in people with multiple sclerosis treated with fumarates

Multiple Sclerosis Journal – Experimental, Translational and Clinical, 2023-07, Vol.9 (3), p.20552173231191170-20552173231191170

2023

Volltextzugriff (PDF)

Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study

Multiple sclerosis, 2013-03, Vol.19 (3), p.316-325

2013

Volltextzugriff (PDF)

Is Primary Progressive Multiple Sclerosis A Disease Entity Of Its Own? - Preliminary Results Of A 7T MRI Study (S54.002)

Neurology, 2014-04, Vol.82 (10_supplement)

2014

Volltextzugriff (PDF)

Different patterns of lesion formation in early and late stages of multiple sclerosis revealed by phase imaging at 7T (P6.115)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

Immortelle essential oil-based ointment improves wound healing in a diabetic rat model

Biomedicine & pharmacotherapy, 2022-06, Vol.150, p.112941-112941, Article 112941

2022

Volltextzugriff (PDF)

The Evaluation of Healing Properties of Galium verum-Based Oral Gel in Aphthous Stomatitis in Rats

Molecules (Basel, Switzerland), 2022-07, Vol.27 (15), p.4680

2022

Volltextzugriff (PDF)

Formulation and Evaluation of Helichrysum italicum Essential Oil-Based Topical Formulations for Wound Healing in Diabetic Rats

Pharmaceuticals (Basel, Switzerland), 2021-08, Vol.14 (8), p.813

2021

Volltextzugriff (PDF)

Determination of 5-caffeoylquinic acid (5-CQA) as one of the major classes of chlorogenic acid in commercial tea and coffee samples

Vojnosanitetski pregled, 2015-11, Vol.72 (11), p.1018-1023

2015

Volltextzugriff (PDF)

H-coloring revisited

Filomat, 2023, Vol.37 (26), p.8747-8754

2023

Volltextzugriff (PDF)

Spatially continuous modeling approach for population persistence in road-fragmented landscapes

Applied mathematical modelling, 2015-09, Vol.39 (17), p.5174-5185

2015

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(28)
Dissertationen
(1)

Sprache

Englisch
(28)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diroximel fumarate pregnancy outcomes in EVOLVE-MS-1 and prospective MS pregnancy exposure registry study design

Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis

Response to Letter to the Editor Regarding “Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis”

Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis

Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM

Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons

Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration

Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase

Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: NEDA-3 after Re-baselining in the Phase 3 EVOLVE-MS-1 Study (P8-3.001)

Long-Term Safety and Effectiveness of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice, an updated analysis of the ESTEEM Study (P7-3.009)

Diroximel Fumarate Pregnancy Outcomes in EVOLVE-MS-1 and Study Design of Diroximel Fumarate Prospective MS Pregnancy Exposure Registry (P9-3.003)

Long-Term Safety and Effectiveness of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice (P7-4.009)

Über die anwendung der ultrahochfeld-magnetresonanztomographie zur detektion verschiedener läsionsmuster bei patienten mit multipler sklerose

Diroximel Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 Study

Identical lesion morphology in primary progressive and relapsing–remitting MS –an ultrahigh field MRI study

Vaccine response in people with multiple sclerosis treated with fumarates

Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study

Is Primary Progressive Multiple Sclerosis A Disease Entity Of Its Own? - Preliminary Results Of A 7T MRI Study (S54.002)

Different patterns of lesion formation in early and late stages of multiple sclerosis revealed by phase imaging at 7T (P6.115)

Immortelle essential oil-based ointment improves wound healing in a diabetic rat model

The Evaluation of Healing Properties of Galium verum-Based Oral Gel in Aphthous Stomatitis in Rats

Formulation and Evaluation of Helichrysum italicum Essential Oil-Based Topical Formulations for Wound Healing in Diabetic Rats

Determination of 5-caffeoylquinic acid (5-CQA) as one of the major classes of chlorogenic acid in commercial tea and coffee samples

H-coloring revisited

Spatially continuous modeling approach for population persistence in road-fragmented landscapes

Suchergebnisse filtern